Dr. Charles Kevin Peirce, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3201 University Dr E, Ste 370, Bryan, TX 77802 Phone: 979-731-8660 |
Dr. Robin Rashmi Bhavsar, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2700 E 29th St Ste 100, Bryan, TX 77802 Phone: 979-774-3041 Fax: 979-774-3053 |
Mr. Alan Keith Young, M. D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1404 Bristol St, Bryan, TX 77802 Phone: 979-779-6615 Fax: 979-823-2785 |
Dr. Samuel Hills Harrison, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3201 University Dr E, Suite 370, Bryan, TX 77802 Phone: 979-731-8660 |
Dr. Kathy Ravanbakhsh, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 2700 E 29th St Ste 100, Bryan, TX 77802 Phone: 979-774-3041 Fax: 979-774-3053 |
Evan Lacefield, Urology Medicare: Accepting Medicare Assignments Practice Location: 2700 E 29th St Ste 100, Bryan, TX 77802 Phone: 979-774-3041 Fax: 979-774-3053 |
Dr. Ralph Raymond Young Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1404 Bristol St, Bryan, TX 77802 Phone: 979-779-6615 Fax: 979-823-2785 |
News Archive
Researchers at the National Eye Institute (NEI) have described the functions of a gene responsible for anchoring cilia - sensory hair-like extensions present on almost every cell of the body.
Scientists battling malaria have earned a major victory. According to a Nature Genetics study, an international group of researchers has used genomics to decode the blueprint of Plasmodium falciparum - a strain of malaria most resistant to drugs that causes the most deaths around the world.
A sports hernia is a common cause of groin pain in athletes, however until lately little has been known as to why they occur. Researchers presenting their study today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting in Baltimore suggest that a type of hip condition (Femoral Acetabular Impingement (FAI) might be a contributing cause.
Shionogi Inc. today announced data from a Phase IIb study that showed 0.2 mg and 0.4 mg of naldemedine demonstrated statistically significant efficacy in treating opioid-induced constipation (OIC) in patients with chronic non-cancer pain.
Metabolix, Inc., a bioscience company focused on developing sustainable solutions for plastics, chemicals and energy, today reported financial results for the three months ended June 30, 2010.
› Verified 6 days ago